Navigator Medicines, Inc. — Form D

Navigator Medicines, Inc. of SCOTCH PLAINS, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-05. The offering totals $100.0M, of which $50.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-09-05
• Form: D
• Accession: 0002035715-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $100.0M
• Amount sold: $50.0M
• Remaining: $50.0M
• Investors: 4
• Date of first sale: 2024-08-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-523299

Issuer

• Name: Navigator Medicines, Inc.
• CIK: 0002035715
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 2525 SMITH STREET, SCOTCH PLAINS, NJ, 07076
• Phone: 518-313-0994

Officers, directors & promoters (8)

More

• CIK 2035715 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search